Navigation Links
OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing
Date:8/21/2014

NEW YORK, Aug. 21, 2014 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM) congratulates Immune Pharmaceuticals Inc., a biotechnology company, on its approval to list on The NASDAQ Capital Market.  Immune previously traded on OTCQX®, the best marketplace for established U.S. and global companies operated by OTC Markets Group.

Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO

"We congratulate Immune Pharmaceuticals on the successful execution of its growth strategy and achievement of this important milestone," said R. Cromwell Coulson, President and CEO of OTC Markets Group.  "OTCQX has provided its investors with an efficient, transparent and information-rich trading market so they can easily analyze, value and trade its securities.  We are proud to have helped contribute to Immune's success as a public company as it takes this next step."     

"Immune Pharma went public one year ago and started trading on OTCQX.  Over the past six months, we have significantly increased our daily trading volume and raised capital to prepare for execution on our clinical milestones and for up-listing.  On Thursday, August 21, 2014, we will begin trading on The Nasdaq Capital Market, enabling additional investors to participate in our story," said Dr. Daniel Teper, CEO of Immune.

OTCQX is the marketplace of choice for U.S. and global companies that are looking to execute their business plans and graduate to a U.S. stock exchange listing.  Immune is the sixth OTCQX company to graduate to the NYSE MKT or NASDAQ markets this year.  Others include: BioPath Holdings Inc., Cellectar Biosciences Inc., Gulf Coast Ultra Deep Loyalty Trust, RXI Pharmaceuticals Corp. and Sphere 3D Corp.

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities.  Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities.  We organize these securities into marketplaces to better inform investors of opportunities and risks – OTCQX®, The Best Marketplace; OTCQB®, The Venture Marketplace; and OTC Pink®, The Open Marketplace.  Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors.  To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets RSS Feed


'/>"/>
SOURCE OTC Markets Group Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Molecular Diagnostics Markets
2. Microarray Markets - 2013 Report Examines Companies that are Actively Developing and Marketing Microarray Instrumentation or Microarray Biochips
3. Stem Cell Markets - 2013 Report Examines the Use of Stem Cells in Developing New Therapies for Disease
4. BCC Research Publishes a New Report On Global Markets for Flow Cytometry
5. Globalizing Clinical Trials to Include Emerging Markets, New Life Science Webinar Hosted by Xtalks
6. BCC Research Publishes a New Report on Global Markets for Biochips
7. BCC Research Publishes a New Report On Global Markets for Rnai Technologies
8. Interventional Cardiology Devices - Emerging Markets 2009-2015
9. IDC MarketScape annovera la soluzione cloud-based di Veeva tra le principali soluzioni CRM dedicate alle scienze della vita
10. IDC MarketScape Named Cloud-based Veeva a Leader in Life Sciences CRM
11. Point of Care Diagnostic Testing: World Markets Report 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)...   Ginkgo Bioworks , a leading organism ... today awarded as one of the World Economic ... most innovative companies. Ginkgo Bioworks is engineering biology ... world in the nutrition, health and consumer goods ... customers including Fortune 500 companies to design microbes ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, into ... for over 35 years, is proud to add Target to its list of ...
Breaking Biology Technology:
(Date:6/2/2016)... YORK , June 2, 2016   The Weather ... is announcing Watson Ads, an industry-first capability in which consumers ... by being able to ask questions via voice or text ... Marketers have long sought ... the consumer, that can be personal, relevant and valuable; and ...
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
Breaking Biology News(10 mins):